NEUROFIBROMATOSIS TYPE 1 (NF 1) & PREGNANCY – CASES WITH ABRUPTIOPLACENTA & IUD-Reference-Cited by-同舟云学术

NEUROFIBROMATOSIS TYPE 1 (NF 1) & PREGNANCY – CASES WITH ABRUPTIOPLACENTA & IUD

Published:2022-01-01 Issue: Volume: Page:71-72
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

T.S.K Sumitra Reddy¹,P Shah Neelima²,M Pawar Suruchi²,D Gheya¹,Suressh Shrradhaa¹,BV Induja¹

Affiliation:

1. Post Graduate, Department of Obstetrics and Gynaecology, DY Patil Medical College, Hospital & Research centre, Kolhapur.

2. Associate Professor, Department of Obstetrics and Gynaecology, DY Patil Medical College, Hospital & Research centre, Kolhapur.

Abstract

Neurobromatosis type 1 (NF - 1) is one of the most common genetic diseases following on Autosomal Dominant pattern. Maternal & Fetal complications have been reported. In some diseases, because of hormonal changes during pregnancy, there will be intensication of the disease. PURPOSE: To report, a very two interesting cases of Neurobromatosis – 1 (NF 1) in pregnancy with Abruptioplacenta & IUD.

Publisher

World Wide Journals

Reference10 articles.

1. GersellDJ, FullingKH. Localized neurofibromatosis of the female genitourinary tract. Am J Surg Pathol 1989;13:873-8

2. Ruggieri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 2001;56:1433-43

3. Colman SD, Rasmussen SA,Ho VT, Abernathy CR, Wallace MR. Somatic mosaicism in a patientwith neurofibromatosis type 1. Am J Hum Genet 1996;58:484-90

4. Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999;89:1-6

5. Leslie KK, White M, Sujansky E. Utilization of Polymerase Chain reaction (PCR) for Identification of Estrogen Receptors in Neurofibromas; Potential Clinical Significance". National Neurofibromatosis Foundation. Annual Clinical Care Conference, 1992.